Analyst Jason Butler from JMP Securities reiterated a Buy rating on Prothena (PRTA – Research Report) and decreased the price target to $80.00 ...

Aridis Pharmaceuticals (ARDS) announced a corporate update on recent developments. The company said, “The Company continues to diligently ...

LOS GATOS, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on recent ...

Sangamo Therapeutics, Inc. has groundbreaking treatments for neuropathic pain and Hemophilia A. Click for my updated look at ...

Consistent positive trends were seen across multiple secondary and exploratory endpoints, Roche said. Prothena went further ...

Secondary immunodeficiency disease (SID) status was associated with significantly higher risk for severe bacterial infections ...

The FDA today issued an alert after Boston Scientific warned of the potential need for the early replacement of certain ...

RiboD-PETRI, a cost-effective, equipment-free plate-based scRNA-seq technique that integrates a unique bacterial rRNA depletion protocol, significantly enhancing mRNA detection rate and revealing ...

Following news of RSV lower respiratory tract infections in infants immunized with Moderna’s investigational RNA vaccines, ...

BeiGene has struck a $150 million deal to license a cancer candidate from CSPC Zhongqi Pharmaceutical Technology, positioning ...

While good dogs never mean harm, they are often directed to remain on-lead in nature reserves to protect wildlife. Research has found that whether dog owners follow this rule is mostly driven by ...

The black box of the human brain is starting to open. Although animal models are instrumental in shaping our understanding of the mammalian brain, scarce human data is uncovering important ...